Merck KGaA (ETR:MRK)
Germany · Delayed Price · Currency is EUR 125.55
-0.30 (-0.24%)
At close: Jan 30, 2026
Merck KGaA Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 21,271 | 21,156 | 20,993 | 22,232 | 19,687 | 17,534 | |
Revenue Growth (YoY) | 1.47% | 0.78% | -5.57% | 12.93% | 12.28% | 8.56% |
Cost of Revenue | 8,748 | 8,632 | 8,558 | 8,500 | 7,325 | 6,782 |
Gross Profit | 12,523 | 12,524 | 12,435 | 13,732 | 12,362 | 10,752 |
Selling, General & Admin | 5,976 | 5,884 | 5,784 | 5,989 | 5,458 | 5,295 |
Research & Development | 2,268 | 2,269 | 2,439 | 2,447 | 2,418 | 2,262 |
Other Operating Expenses | -2 | 274 | 510 | 325 | 177 | 119 |
Operating Expenses | 8,253 | 8,438 | 8,735 | 8,754 | 8,056 | 7,681 |
Operating Income | 4,270 | 4,086 | 3,700 | 4,978 | 4,306 | 3,071 |
Interest Expense | -277 | -229 | -260 | -196 | -245 | -328 |
Interest & Investment Income | 94 | 164 | 172 | 71 | 46 | 39 |
Currency Exchange Gain (Loss) | 20 | 20 | 51 | -109 | -34 | -60 |
Other Non Operating Income (Expenses) | 31 | 30 | 26 | -3 | 14 | 2 |
EBT Excluding Unusual Items | 4,138 | 4,071 | 3,689 | 4,741 | 4,087 | 2,724 |
Merger & Restructuring Charges | -144 | -144 | -248 | -199 | -141 | -360 |
Gain (Loss) on Sale of Assets | 110 | -3 | 132 | 45 | 63 | 94 |
Asset Writedown | -328 | -328 | -98 | -232 | -54 | -183 |
Legal Settlements | -48 | -48 | -1 | -6 | 8 | 372 |
Other Unusual Items | -11 | -11 | 10 | -61 | -39 | -16 |
Pretax Income | 3,717 | 3,537 | 3,484 | 4,288 | 3,924 | 2,631 |
Income Tax Expense | 756 | 751 | 650 | 948 | 859 | 637 |
Earnings From Continuing Operations | 2,961 | 2,786 | 2,834 | 3,340 | 3,065 | 1,994 |
Net Income to Company | 2,961 | 2,786 | 2,834 | 3,340 | 3,065 | 1,994 |
Minority Interest in Earnings | -5 | -9 | -10 | -14 | -10 | -7 |
Net Income | 2,956 | 2,777 | 2,824 | 3,326 | 3,055 | 1,987 |
Net Income to Common | 2,956 | 2,777 | 2,824 | 3,326 | 3,055 | 1,987 |
Net Income Growth | 9.64% | -1.66% | -15.09% | 8.87% | 53.75% | 50.53% |
Shares Outstanding (Basic) | 435 | 435 | 435 | 435 | 435 | 435 |
Shares Outstanding (Diluted) | 435 | 435 | 435 | 435 | 435 | 435 |
Shares Change (YoY) | -0.06% | - | - | - | - | - |
EPS (Basic) | 6.80 | 6.39 | 6.50 | 7.65 | 7.03 | 4.57 |
EPS (Diluted) | 6.80 | 6.39 | 6.49 | 7.65 | 7.03 | 4.57 |
EPS Growth | 9.81% | -1.58% | -15.16% | 8.87% | 53.75% | 50.61% |
Free Cash Flow | 2,299 | 2,884 | 1,977 | 2,728 | 3,550 | 2,064 |
Free Cash Flow Per Share | 5.29 | 6.63 | 4.55 | 6.27 | 8.16 | 4.75 |
Dividend Per Share | 2.200 | 2.200 | 2.200 | 2.200 | 1.850 | 1.400 |
Dividend Growth | - | - | - | 18.92% | 32.14% | 7.69% |
Gross Margin | 58.87% | 59.20% | 59.23% | 61.77% | 62.79% | 61.32% |
Operating Margin | 20.07% | 19.31% | 17.63% | 22.39% | 21.87% | 17.52% |
Profit Margin | 13.90% | 13.13% | 13.45% | 14.96% | 15.52% | 11.33% |
Free Cash Flow Margin | 10.81% | 13.63% | 9.42% | 12.27% | 18.03% | 11.77% |
EBITDA | 5,771 | 5,782 | 5,378 | 6,522 | 5,788 | 4,591 |
EBITDA Margin | 27.13% | 27.33% | 25.62% | 29.34% | 29.40% | 26.18% |
D&A For EBITDA | 1,501 | 1,696 | 1,678 | 1,544 | 1,482 | 1,520 |
EBIT | 4,270 | 4,086 | 3,700 | 4,978 | 4,306 | 3,071 |
EBIT Margin | 20.07% | 19.31% | 17.63% | 22.39% | 21.87% | 17.52% |
Effective Tax Rate | 20.34% | 21.23% | 18.66% | 22.11% | 21.89% | 24.21% |
Advertising Expenses | - | 526 | 515 | 476 | 461 | 413 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.